A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12

Nature Genetics

Volumn 45, Issue 8, 2013, Pages 918-922

  Shi, Yongyong ^a,c,d   Li, Li ^e   Hu, Zhibin ^f   Li, Shuang ^a   Wang, Shixuan ^a   Liu, Jihong ^g   Wu, Chen ^h   He, Lin ^b,c,d   Zhou, Jianfeng ^a   Li, Zhiqiang ^b,c,d   Hu, Ting ^a   Chen, Yile ⁱ   Jia, Yao ^a   Wang, Shaoshuai ^a   Wu, Li ⁱ   Cheng, Xiaodong ^j   Yang, Zhijun ^e   Yang, Ru ^a   Li, Xiong ^a   Huang, Kecheng ^a   Zhang, Qinghua ^a   Zhou, Hang ^a   Tang, Fangxu ^a   Chen, Zhilan ^a   Shen, Jian ^a   Jiang, Jie ^f   Ding, Hu ^a   Xing, Hui ^k   Zhang, Shulan ^l   Qu, Pengpeng ^m   Song, Xiaojie ⁿ   Lin, Zhongqiu ^o   Deng, Dongrui ^a   Xi, Ling ^a   Lv, Weiguo ^j   Han, Xiaobing ^p   Tao, Guangshi ^q   Yan, Lixing ^r   Han, Zhedong ^r   Li, Zhuang ^e   Miao, Xiaoping ^s   Pan, Shandong ^f   Shen, Yuanming ^j   Wang, Hui ^a   Liu, Dan ^a   Gong, Ee ^a   Li, Zheng ^g   Zhou, Limei ^m   Luan, Xiaomei ^l   Wang, Chuping ^t   Song, Qian ^u   Wu, Sufang ^v   Xu, Hongbin ^w   Shen, Jiawei ^b,c,d   Qiang, Fulin ^x   Ma, Gang ^y   Liu, Li ^x   Chen, Xiaojun ^x   Liu, Jibin ^x   Wu, Jiangping ^z   Shen, Yan ^z   Wen, Yang ^f   Chu, Minjie ^f   Yu, Jiang ^aa   Hu, Xiaoxia ^ab   Fan, Yujuan ^ac   He, Hongying ^ad   Jiang, Yanming ^ae   Lei, Zhiying ^af   Liu, Cui ^ag   Chen, Jianhua ^b,ah   Zhang, Yuan ^a   Yi, Cunjian ^ai   Chen, Shuangyun ^aj   Li, Wenjin ^b   Wang, Daowen ^a   Wang, Zehua ^a   Di, Wen ^ak   Shen, Keng ^al   Lin, Dongxin ^h   Shen, Hongbing ^f   Feng, Youji ^v   Xie, Xing ^j   Ma, Ding ^a   more..

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c Shanghai GenomePilot Institutes for Genomics and Human Health   (China)

^d Changning Mental Health Center   (China)

^e Guangxi province Tumor Institute   (China)

^f NANJING MEDICAL UNIVERSITY   (China)

^g SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^h CANCER HOSPITAL   (China)

ⁱ HUNAN CANCER HOSPITAL   (China)

^j ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^k HUBEI UNIVERSITY OF ARTS AND SCIENCE   (China)

^l CHINA MEDICAL UNIVERSITY   (China)

^m Tianjin Central Hospital for Obstetrics and Gynecology   (China)

ⁿ Wuhan Medical Care Center for Women and Children   (China)

^o SUN YAT SEN UNIVERSITY   (China)

^p MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^q CENTRAL SOUTH UNIVERSITY   (China)

^r BEIJING HOSPITAL   (China)

^s BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^t Huangshi Central Hospital   (China)

^u Xiaogan Central Hospital of Jinzhou Medical University   (China)

^v FUDAN UNIVERSITY   (China)

^w SHENZHEN PEOPLE'S HOSPITAL   (China)

^x NANTONG TUMOR HOSPITAL   (China)

^y Guangxi Matemal and Child Health Hospital   (China)

^z WOMEN S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^aa People's Liberation Army 181 Hospital   (China)

^ab PEOPLE'S HOSPITAL OF GUANGXI ZHUANG AUTONOMOUS REGION   (China)

^ac FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

^ad Department of Otolaryngology and Head and Neck Surgery   (China)

^ae LIUZHOU PEOPLE S HOSPITAL   (China)

^af YOUJIANG MEDICAL COLLEGE FOR NATIONALITIES   (China)

^ag Red Cross Hospital of Yulin City   (China)

^ah SHANGHAI MENTAL HEALTH CENTER   (China)

^ai First People's Hospital of Jingzhou City   (China)

^aj Taihe Hospital of Shiyan   (China)

^ak SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^al PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HLA DP ANTIGEN; HLA DPB1 ANTIGEN; HLA DPB2 ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; CANCER PATIENT; CANCER SUSCEPTIBILITY; CHINESE; CHROMOSOME 17Q12; CHROMOSOME 4Q12; CHROMOSOME ABERRATION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; GENE FREQUENCY; GENE LOCUS; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC RISK; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PATIENT SELECTION; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 4; COMPUTATIONAL BIOLOGY; FEMALE; FOLLOW-UP STUDIES; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; REPRODUCIBILITY OF RESULTS; UTERINE CERVICAL NEOPLASMS;

EID: 84881023826     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.2687     Document Type: Article

References (41)

1. Arbyn, M. et al. Worldwide burden of cervical cancer in 2008. Ann. Oncol. 22, 2675-2686 (2011).
2. Parkin, D.M., Bray, F., Ferlay, J. & Pisani, P. Global cancer statistics, 2002. CA Cancer J. Clin. 55, 74-108 (2005).
3. zur Hausen, H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J. Natl. Cancer Inst. 92, 690-698 (2000).
4. zur Hausen, H. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2, 342-350 (2002).
5. Walboomers, J.M. et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189, 12-19 (1999).
6. Chen, T.M., Pecoraro, G. & Defendi, V. Genetic analysis of in vitro progression of human papillomavirus-transfected human cervical cells. Cancer Res. 53, 1167-1171 (1993).
7. Baseman, J.G. & Koutsky, L.A. The epidemiology of human papillomavirus infections. J. Clin. Virol. 32 (suppl. 1), S16-S24 (2005).
8. Ho, G.Y., Bierman, R., Beardsley, L., Chang, C.J. & Burk, R.D. Natural history of cervicovaginal papillomavirus infection in young women. N. Engl. J. Med. 338, 423-428 (1998).
9. Kulasingam, S.L. et al. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. J. Am. Med. Assoc. 288, 1749-1757 (2002).
10. Dalstein, V. et al. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study. Int. J. Cancer 106, 396-403 (2003).
11. Magnusson, P.K., Lichtenstein, P. & Gyllensten, U.B. Heritability of cervical tumours. Int. J. Cancer 88, 698-701 (2000).
12. Ivansson, E.L., Juko-Pecirep, I., Erlich, H.A. & Gyllensten, U.B. Pathway-based analysis of genetic susceptibility to cervical cancer in situ: HLA-DPB1 affects risk in Swedish women. Genes Immun. 12, 605-614 (2011).
13. Freedman, M.L. et al. Assessing the impact of population stratification on genetic association studies. Nat. Genet. 36, 388-393 (2004).
14. de Bakker, P.I. et al. Practical aspects of imputation-driven meta-analysis of genome-wide association studies. Hum. Mol. Genet. 17, R122-R128 (2008).
15. Sugihara, K. et al. The exocyst complex binds the small GTPase RalA to mediate filopodia formation. Nat. Cell Biol. 4, 73-78 (2002).
16. Munson, M. & Novick, P. The exocyst defrocked, a framework of rods revealed. Nat. Struct. Mol. Biol. 13, 577-581 (2006).
17. Rosse, C. et al. An aPKC-exocyst complex controls paxillin phosphorylation and migration through localised JNK1 activation. PLoS Biol. 7, e1000235 (2009).
18. Zuo, X. et al. Exo70 interacts with the Arp2/3 complex and regulates cell migration. Nat. Cell Biol. 8, 1383-1388 (2006).
19. Ishikawa, H., Ma, Z. & Barber, G.N. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 461, 788-792 (2009).
20. Bourgault Villada, I. et al. Spontaneous regression of grade 3 vulvar intraepithelial neoplasia associated with human papillomavirus-16-specific CD4+ and CD8+ T-cell responses. Cancer Res. 64, 8761-8766 (2004).
21. Nicol, A.F. et al. Immune factors involved in the cervical immune response in the HIV/HPV co-infection. J. Clin. Pathol. 61, 84-88 (2008).
22. Roeth, J.F. & Collins, K.L. Human immunodeficiency virus type 1 Nef: adapting to intracellular trafficking pathways. Microbiol. Mol. Biol. Rev. 70, 548-563 (2006).
23. Fenard, D. et al. Nef is physically recruited into the immunological synapse and potentiates T cell activation early after TCR engagement. J. Immunol. 175, 6050-6057 (2005).
24. Schrager, J.A. & Marsh, J.W. HIV-1 Nef increases T cell activation in a stimulus-dependent manner. Proc. Natl. Acad. Sci. USA 96, 8167-8172 (1999).
25. Mukerji, J., Olivieri, K.C., Misra, V., Agopian, K.A. & Gabuzda, D. Proteomic analysis of HIV-1 Nef cellular binding partners reveals a role for exocyst complex proteins in mediating enhancement of intercellular nanotube formation. Retrovirology 9, 33 (2012).
26. Di Bonito, P. et al. Anti-tumor CD8+ T cell immunity elicited by HIV-1-based virus-like particles incorporating HPV-16 E7 protein. Virology 395, 45-55 (2009).
27. Tamura, M. et al. Members of a novel gene family, Gsdm, are expressed exclusively in the epithelium of the skin and gastrointestinal tract in a highly tissue-specific manner. Genomics 89, 618-629 (2007).
28. Carl-McGrath, S., Schneider-Stock, R., Ebert, M. & Rocken, C. Differential expression and localisation of gasdermin-like (GSDML), a novel member of the cancer-associated GSDMDC protein family, in neoplastic and non-neoplastic gastric, hepatic, and colon tissues. Pathology 40, 13-24 (2008).
29. Sun, Q., Yang, J., Xing, G., Zhang, L. & He, F. Expression of GSDML associates with tumor progression in uterine cervix cancer. Transl. Oncol. 1, 73-83 (2008).
30. Saeki, N. et al. GASDERMIN, suppressed frequently in gastric cancer, is a target of LMO1 in TGF-β-dependent apoptotic signalling. Oncogene 26, 6488-6498 (2007).
31. Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559-575 (2007).
32. de Bakker, P.I. et al. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat. Genet. 38, 1166-1172 (2006).
33. Wirtz, C. & Sayer, D. Data analysis of HLA sequencing using Assign-SBT v3.6+ from Conexio. Methods Mol. Biol. 882, 87-121 (2012).
34. Price, A.L. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38, 904-909 (2006).
35. Solovieff, N. et al. Clustering by genetic ancestry using genome-wide SNP data. BMC Genet. 11, 108 (2010).
36. Saxena, R. et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316, 1331-1336 (2007).
37. Shi, Y.Y. & He, L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 15, 97-98 (2005).
38. Mantel, N. & Haenszel, W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 22, 719-748 (1959).
39. Setakis, E., Stirnadel, H. & Balding, D.J. Logistic regression protects against population structure in genetic association studies. Genome Res. 16, 290-296 (2006).
40. Harley, J.B. et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat. Genet. 40, 204-210 (2008).
41. Marchini, J., Howie, B., Myers, S., McVean, G. & Donnelly, P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat. Genet. 39, 906-913 (2007).